Cardiac function in trisomy 21 fetuses

Ultrasound in Obstetrics and Gynecology

Volumn 37, Issue 2, 2011, Pages 163-171

  Clur, S A B ^a,b   Oude Rengerink, K ^c   Ottenkamp, J ^a,b   Bilardo, C M ^c,d  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b Centre for Congenital Heart Anomalies Amsterdam Leiden   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

cardiac function; Doppler; ductus venosus; fetus; nuchal translucency; trisomy 21

Indexed keywords

ARTICLE; BLOOD FLOW VELOCITY; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DOWN SYNDROME; DUCTUS ARTERIOSUS; ECHOGRAPHY; FEMALE; FETUS HEART; GESTATIONAL AGE; HUMAN; METHODOLOGY; NUCHAL TRANSLUCENCY MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; PROSPECTIVE STUDY;

BLOOD FLOW VELOCITY; DOWN SYNDROME; DUCTUS ARTERIOSUS; FEMALE; FETAL HEART; GESTATIONAL AGE; HEART DEFECTS, CONGENITAL; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PROSPECTIVE STUDIES;

EID: 79251564079     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.8819     Document Type: Article

References (51)

1. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K,. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-869.
2. Pajkrt E, Bilardo CM, van Lith JMM, Mol BWJ, Bleker OP,. Nuchal translucency measurement in normal fetuses. Obstet Gynecol 1995; 86: 994-997.
3. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O,. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221-226.
4. von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH,. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol 1998; 91: 319-323.
5. von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B,. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse. Anat Embryol 1998; 197: 105-124.
6. Brand-Saberi B, Floel H, Christ B, Schulte-Vallentin M, Schindler H,. Alterations of the fetal extracellular matrix in the nuchal oedema of Down's syndrome. Ann Anat 1994; 176: 539-547.
7. Haak MC, Bartelings MM, Jackson DG, Webb S, van Vugt JM, Gittenberger-de Groot AC,. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod 2002; 17: 1086-1092.
8. Bekker MN, Arkensteijn JB, van den Akker NMS, Hoffman S, Webb S, van Vugt JMG, Gittenberger-de Groot A,. Increased NCAM expression and vascular development in trisomy 16 mouse embryos: relationship with nuchal translucency. Pediatr Res 2005; 58: 1222-1227.
9. Montenegro N, Matias A, Areias JC, Castedo S, Barros H,. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997; 10: 265-268.
10. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH,. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol 1999; 14: 307-310.
11. Bilardo CM, Pajkrt E, de Graaf I, Mol BW, Bleker OP,. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 1998; 6: 388-390.
12. Bilardo CM, Müller MA, Zikulnig L, Schipper M, Hecher K,. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 2001; 17: 288-294.
13. Hyett JA, Brizot ML, von Kaisenberg CS, McKie AT, Farzaneh F, Nicolaides KH,. Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses. Obstet Gynecol 1996; 87: 506-510.
14. Hyett J, Moscoso G, Papanagiotou G, Perdu M, Nicolaides KH,. Abnormalities of the heart and great arteries in chromosomally normal fetuses with an increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 1996; 7: 245-250.
15. Hyett J, Moscoso G, Nicolaides K,. Increased nuchal translucency in trisomy 21 fetuses: relationship to narrowing of the aortic isthmus. Hum Reprod 1995; 10: 30-36.
16. Huggon IC, Turan O, Allan LD,. Doppler assessment of cardiac function at 11-14 weeks' gestation in fetuses with normal and increased nuchal translucency. Ultrasound Obstet Gynecol 2004; 24: 390-398.
17. Brestak M, Calda P, Tomak V, Siegl T,. LV shortening fraction-a new ultrasound marker of trisomy 21 in the first trimester. Abstract OC04.02. Ultrasound Obstet Gynecol 2009; 34: 6.
18. Zoppi MA, Ibba RM, Floris M, Manca F, Axiana C, Monni G,. Intracardiac Doppler assessment of left valve inflow in first-trimester fetuses with increased nuchal translucency: preliminary observations in trisomy 21. Ultrasound Obstet Gynecol 2006; 28: 77-81.
19. Lee W, Allan L, Carvalho JS, Chaoui R, Copel J, Devore G, Hecher K, Munoz H, Nelson T, Paladini D, Yagel S,; ISUOG Fetal Echocardiography Task Force. ISUOG consensus statement: what constitutes a fetal echocardiogram? Ultrasound Obstet Gynecol 2008; 32: 239-242.
20. Simpson JM, Cook A,. Repeatability of echocardiographic measurements in the human fetus. Ultrasound Obstet Gynecol 2002; 20: 332-339.
21. Raboisson MJ, Bourdages M, Fouron JC,. Measuring left ventricular myocardial performance in fetuses. Am J Cardiol 2003; 91: 919-921.
22. Hernandez-Andrade E, Lopez-Tenorio J, Figueroa-Diesel H, Sanin-Blair J, Carreras E, Cabero L, Gratacos E,. A modified myocardial performance (Tei) index based on the use of valve clicks improves reproducibility of fetal left cardiac function measurement. Ultrasound Obstet Gynecol 2005; 26: 227-232.
23. Geva T,. Echocardiography and Doppler ultrasound. In The Science and Practice of Pediatric Cardiology, Garson A, Bricker JT, Fisher DJ, Neish S, (eds). Williams and Wilkins: Baltimore, 1998; 834-844.
24. Tei C, Ling L, Hodge D, Bailey K, Ok J, Rodenheffer R, Tajik A, Steward J,. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normal and dilated cardiomyopathy. J Cardiol 1995; 26: 357-366.
25. St John Sutton M, Gill T, Plappert T, Saltzman DH, Doubilet P,. Assessment of right and left ventricular function in terms of force development with gestational age in the normal fetus. Br Heart J 1991; 66: 285-289.
26. Teixeira LS, Leite J, Viegas MJ, Faria MM, Chaves AS, Teixeira RC, Pires MC, Pettersen H,. Ductus venosus Doppler velocimetry in the first trimester: a new finding. Ultrasound Obstet Gynecol 2008; 31: 261-265.
27. Clur SAB, Oude Rengerink K, Mol BWJ, Ottenkamp J, Bilardo CM,. Fetal cardiac function between 11 and 35 weeks' gestation and nuchal translucency thickness. Ultrasound Obstet Gynecol 2011; 37: 48-56.
28. Pacileo G, Paladini D, Pisacane C, Palmieri S, Russo MG, Calabrio R,. Role of changing loading condition on atrioventricular flow velocity patterns in normal human fetuses. Am J Cardiol 1994; 73: 991-993.
29. Gardin JG,. Doppler measurements of aortic blood flow velocity and acceleration: load independent indexes of left ventricular performance? Am J Cardiol 1989; 64: 935-936.
30. St John Sutton M, Wiegers SE,. The Tei Index:-a role in the diagnosis of heart failure? Eur Heart J 2000; 21: 1822-1824.
31. Miki S, Murakami T, Iwase T, Tomita T, Nakamwa Y, Kawai C,. Doppler echocardiographic transmitral peak early velocity does not directly reflect hemodynamic changes in humans: importance of normalization to mitral stroke volume. J Am Coll Cardiol 1991; 17: 1507-1516.
32. Mercé LT, Barco MJ, Alcázar JL, Sabatel R, Troyano J,. Intervillous and uteroplacental circulation in normal early pregnancy and early pregnancy loss assessed by 3-dimensional power Doppler angiography. Am J Obstet Gynecol 2009; 200: 315.e1-e8.
33. Leiva MC, Tolosa JE, Binotto CN, Wiener S, Huppert L, Denis AL, Huhta JC,. Fetal cardiac development and hemodynamics in the first trimester. Ultrasound Obstet Gynecol 1999; 14: 167-174.
34. Zoppi MA, Ibba RM, Putzolu M, Floris M, Monni G,. First trimester umbilical artery pulsatility index in fetuses presenting with an enlarged nuchal translucency. Prenat Diagn 2000; 20: 701-704.
35. Mäkikallio K, Jouppila P, Räsänen J,. Human fetal cardiac function in the first trimester of pregnancy. Heart 2005; 91: 334-338.
36. Huggon IC, DeFigueiredo DB, Allan LD,. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 10-14 weeks of gestation. Heart 2003; 89: 1071-1073.
37. Zoppi MA, Putzolu M, Ibba RM, Floris M, Monni G,. First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype. Fetal Diagn Ther 2002; 17: 52-57.
38. Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH,. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan. Ultrasound Obstet Gynecol 2005; 26: 22-27.
39. Bellotti M, Pennati G, De Gasperi C, Bozz M, Battaglia FC, Ferrazzi E,. Simultaneous measurements of umbilical venous, fetal hepatic, and ductus venosus blood flow in growth-restricted human fetuses. Am J Obstet Gynecol 2004; 190: 1347-1358.
40. Allan LD,. The mystery of the nuchal translucency. The Mannheimer Lecture. Cardiol Young 2006; 16: 11-17.
41. Perrone S, Lingini M, Bellieni CV, Centini G, Kenanidis A, De Marco L, Petraglia F, Buonocore G,. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome. Clin Biochem 2007; 40: 177-180.
42. Bilardo CM, Timmerman E, Robles de Medina PG, Clur SAB,. Low resistance hepatic artery flow in first trimester fetuses: an ominous sign. Ultrasound Obstet Gynecol (in press). DOI: 10.1002/uog.7766.
43. Brown R, Di Luzio L, Gomes C, Nicolaides KH,. The umbilical artery pulsatility index in the first trimester: is there an association with increased nuchal translucency or chromosomal abnormality? Ultrasound Obstet Gynecol 1998; 12: 244-247.
44. Mäkikallio K, Tekay A, Joupila P,. Uteroplacental hemodynamics during early human pregnancy: a longitudinal study. Gynecol Obstet Invest 2004; 58: 49-54.
45. Roberts L, Sebire NJ, Fowler D, Nicolaides KH,. Histomorphological features of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies. Placenta 2000; 21: 678-683.
46. Rochelson B, Kaplan C, Guzman E, Arato M, Hansen K, Trunca C,. A quantitative analysis of placental vasculature in the third trimester fetus with autosomal trisomy. Obstet Gynecol 1990; 75: 59-63.
47. Wong G, Levine D,. Fetuses with trisomy 21 having conflicting findings on antenatal testing for fetal well-being. J Ultrasound Med 2005; 24: 1541-1545.
48. Maiz N, Dagklis T, Huggon I, Allan L, Nicolaides KH,. The mitral gap at 11 + 0 to 13 + 6 weeks: marker of trisomy 21 or artifact? Ultrasound Obstet Gynecol 2007; 30: 813-818.
49. Liao AW, Snijders R, Geerts L, Spencer K, Nicolaides,. Fetal heart rate in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol 2000; 16: 610-613.
50. Haak MC, Twisk JW, Bartelings MM, Gittenberger-de Groot AC, van Vugt JM,. First-trimester fetuses with increased nuchal translucency do not show altered intracardiac flow velocities. Ultrasound Obstet Gynecol 2005; 25: 246-252.
51. Ninno MAP, Liao AW, Lamberty CO, Miquelez J, Zugaib M,. Fetal tricuspid valve Doppler at 11-13 weeks and 9 days: reference values and reproducibility. Prenat Diagn 2010; 30: 790-794.